Edition:
United States

Novelion Therapeutics Inc (NVLN.OQ)

NVLN.OQ on NASDAQ Stock Exchange Global Select Market

3.56USD
18 Jul 2018
Change (% chg)

$0.19 (+5.64%)
Prev Close
$3.37
Open
$3.38
Day's High
$3.71
Day's Low
$3.38
Volume
8,467
Avg. Vol
25,581
52-wk High
$9.58
52-wk Low
$3.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.07 December 18 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2 35.05 36.20 33.90 --
Quarter Ending Dec-18 2 41.30 42.30 40.30 --
Year Ending Dec-18 2 138.90 139.00 138.80 189.71
Year Ending Dec-19 2 167.60 184.80 150.40 212.13
Earnings (per share)
Quarter Ending Sep-18 1 -0.07 -0.07 -0.07 --
Quarter Ending Dec-18 1 0.14 0.14 0.14 --
Year Ending Dec-18 1 -1.53 -1.53 -1.53 -0.30
Year Ending Dec-19 1 1.24 1.24 1.24 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 35.10 27.48 7.62 21.70
Quarter Ending Dec-17 32.78 38.91 6.13 18.70
Quarter Ending Sep-17 35.95 28.67 7.28 20.25
Quarter Ending Jun-17 36.86 40.88 4.02 10.91
Quarter Ending Mar-17 35.55 29.98 5.57 15.66

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 35.05 35.05 35.05 35.05 --
Quarter Ending Dec-18 41.30 41.30 41.30 41.30 --
Year Ending Dec-18 138.90 138.90 138.90 138.90 189.71
Year Ending Dec-19 167.60 167.60 167.60 167.60 212.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings